Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors

Clinical trial NCT06963814 · RECRUITING

Trial details

NCT number: NCT06963814
Sponsor: HC Biopharma Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2025-07-04
Primary completion: 2026-05-30
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.